Five things for pharma marketers to know: Friday, September 23, 2016

Photo credit: Lonnie Tague for the Department of Justice

1. Anthem and Cigna blamed each other for violating the terms of their merger, according to a legal filing by the Department of Justice Department, which is suing the health insurers to stop the $48 billion deal. (WSJ)

2. Lundbeck's idalopirdine, an experimental treatment for Alzheimer's disease, failed to prevent cognitive decline in a late-stage study, according to the Alzheimer's Disease Assessment Scale-Cognitive Subscale. The failed study drove shares down for both the Danish drugmaker and Axovant Sciences, which is developing a similar drug. (Reuters)

3. A different approach will be necessary to eradicate global epidemics such as tuberculosis and HIV by 2030, the Bill & Melinda Gates Foundation said. No country has met any of the health targets proposed in the U.N.'s sustainable development agenda, which include the elimination of disease epidemics and a decrease of conditions such as childhood obesity. (The Guardian)

4. Critics denounced an ad developed by Italy's Ministry of Health aimed at reversing low birthrates as sexist and racist. In celebration of the country's first-ever Fertility Day, four light-skinned adults in the ad were portrayed as having “good habits”, while a darker image including a black man smoking, illustrating “bad habits.” Italy's health minister said there was a mix-up, and that she had approved a different ad. (CBS News)

5. ICYMI: Facebook co-founder Mark Zuckerberg and his wife Priscilla Chan said they will invest $3 billion in an initiative that seeks to prevent, cure, and manage all diseases by the end of the century, as part of the Chan Zuckerberg Initiative. (NYT)